Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 440,799 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on May 16, 2022, when has been sold 5,675 shares (ResMed Common Stock) at a price of $57.76 per share, resulting in proceeds of $327,788. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 441K

0.49% 3M change

0.89% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,935 ResMed Common Stock
Apr 18 2022	SELL Open market or private sale	$1,318,927 $232.41 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Mar 15 2022	SELL Open market or private sale	$1,375,450 $242.37 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Mar 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Feb 15 2022	SELL Open market or private sale	$1,328,290 $234.06 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock

Jan 18 2022	SELL Open market or private sale	$1,373,010 $241.94 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Dec 15 2021	SELL Open market or private sale	$1,450,133 $255.53 p/Share	5,675 Reduced 1.38%	405,229 ResMed Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.36%	410,904 ResMed Common Stock
Nov 19 2021	SELL Bona fide gift	-	44,250 Reduced 9.84%	405,229 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	4,469 Added 0.98%	449,479 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$10,755,530 $254.81 p/Share	42,210 Reduced 8.66%	445,010 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$18,158,270 $254.81 p/Share	71,262 Added 12.76%	487,220 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$2,269,844 $259.47 p/Share	8,748 Reduced 2.06%	415,958 ResMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	18,418 Added 4.16%	424,611 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	7,014 Added 1.7%	406,160 ResMed Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$10,688,899 $214.74 p/Share	49,776 Reduced 11.09%	399,146 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$19,162,969 $214.74 p/Share	89,238 Added 16.58%	448,922 ResMed Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$1,826,479 $212.11 p/Share	8,611 Reduced 2.34%	359,684 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF